OncoSec Medical Inc (OTC:ONCS) cut off the loss unexpectedly. After numerous negative price changes, yesterday the stock 
moved up 12.50% and its traded volume increased significantly. However, the reason for the sudden gain cannot be explained yet.
The latest news by OncoSec dates from July 11, when the company reported it was going to present at the DNA Vaccines Conference held July 12-14, this year. Being published, the announcement didn’t give any credits to ONCS, thus the company made another effort to push up its stock price. This time by promotions.
On the day after the conference news, ONCS was promoted by the well-known Investors Hub, which posted a buyout alert on the stock. However, despite the promotion ONCS kept moving down until yesterday. Will the climb continue today is just about to be seen. In any case, some news by OncoSec is expected soon.
Meanwhile, the company’s financials don’t look improved. According to the 10-Q, total assets of ONCS are not much higher than its liabilities and the company has an accumulated deficit as well as an uncovered net loss. At the same time, basic and diluted net loss points $0.01 per share.[BANNER]
As already reported on hotstocked.com, OncoSec has funded its operations primarily through equity and debt financing and management expects to continue to do so in the future. However, the team claims that if they raise additional financing by issuing equity securities their existing stockholders’ ownership will be diluted. Thus, the company’s future operation remains under a substantial doubt.
